V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008656 | 280005884 | 1.82 | 93 | Palliative (P) | 2013-05-18 | 2013-05-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 280028368 | CISPLATIN + GEMCITABINE |
| 280008657 | 280005885 | 1.6 | 56 | Palliative (P) | 2017-12-03 | 2017-12-08 | Etoposide + Ifosfamide (5 days) | N | N | 280028372 | ETOPOSIDE + IFOSFAMIDE |
| 280008658 | 280005886 | 1.69 | 88.3 | Palliative (P) | 2016-07-09 | 2016-07-09 | CARBOPLATIN + PACLITAXEL | 02 | N | 280028376 | CARBOPLATIN + PACLITAXEL |
| 280008659 | 280005887 | null | 107.6 | Adjuvant (A) | 2017-12-16 | 2017-12-16 | Doxorubicin + Ifosfamide | N | N | 280028396 | DOXORUBICIN + IFOSFAMIDE |
| 280008660 | 280005888 | null | 61.7 | Adjuvant (A) | 2017-09-24 | 2018-03-16 | EURO-EWING | null | null | 280028405 | EURO-EWING |
| 280008661 | 280005888 | 1.87 | 95.1 | Curative (C) | 2015-01-17 | 2015-06-04 | Doxorubicin + Ifosfamide | N | N | 280028405 | DOXORUBICIN + IFOSFAMIDE |
| 280008662 | 280005888 | 1.66 | 64.2 | Palliative (P) | 2018-09-18 | 2018-10-26 | CISPLATIN + FLUOROURACIL | N | N | 280028405 | CISPLATIN + FLUOROURACIL |
| 280008663 | 280005888 | 1.59 | null | Palliative (P) | 2014-12-15 | 2014-12-15 | VAC | N | N | 280028405 | CAV |
| 280008664 | 280005891 | 1.68 | 57.65 | Palliative (P) | 2015-09-11 | 2015-10-28 | EW EuroEwing 99 : VActI | N | N | 280028410 | EURO-EWING |
| 280008665 | 280005894 | 1.71 | 63 | Curative (C) | null | 2014-05-22 | Gemcitabine day 1&8 | null | null | 280028413 | GEMCITABINE |
| 280008666 | 280005895 | 1.86 | null | Disease modification (D) | 2018-02-13 | 2018-07-01 | Carboplatin + Paclitaxel (weekly) | N | N | 280028415 | CARBOPLATIN + PACLITAXEL |
| 280008667 | 280005896 | 1.88 | 96.3 | Palliative (P) | 2013-09-27 | 2013-10-01 | Irinotecan + Temozolomide | Y | N | 280028420 | IRINOTECAN + TEMOZOLOMIDE |
| 280008668 | 280009090 | 1.7 | 75.6 | Palliative (P) | 2013-01-17 | 2013-06-24 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280028420 | CISPLATIN + FLUOROURACIL |
| 280008669 | 280005900 | null | null | Palliative (P) | 2015-07-08 | 2015-07-14 | Doxorubicin + Ifosfamide | N | null | 280028425 | DOXORUBICIN + IFOSFAMIDE |
| 280008670 | 280005900 | 1.55 | 55 | Neo-adjuvant (N) | 2016-03-10 | 2016-03-10 | Doxorubicin + Ifosfamide | N | N | 280028425 | DOXORUBICIN + IFOSFAMIDE |
| 280008671 | 280005903 | 1.77 | 66 | Palliative (P) | 2017-04-29 | 2017-09-20 | Cisplatin+Gemcitabine (gallbladder) | null | null | 280028433 | CISPLATIN + GEMCITABINE |
| 280008672 | 280005907 | 1.59 | null | Palliative (P) | 2014-06-26 | 2014-07-17 | Carboplatin + Etoposide iv&po | N | N | 280028439 | CARBOPLATIN + ETOPOSIDE |
| 280008673 | 280005908 | 1.66 | 73.4 | Neo-adjuvant (N) | 2013-07-25 | 2013-08-09 | DE-ESCALATE TRIAL | 02 | N | 280028440 | DE-ESCALATE TRIAL |
| 280008674 | 280005910 | 1 | 82.2 | Palliative (P) | 2015-07-06 | 2015-07-24 | Carboplatin + Etoposide IV 3 day | N | N | 280028441 | CARBOPLATIN + ETOPOSIDE |
| 280008675 | 280005910 | 1.82 | 65.2 | Palliative (P) | 2013-03-12 | 2013-04-21 | Doxorubicin + Ifosfamide | N | N | 280028441 | DOXORUBICIN + IFOSFAMIDE |
| 280008676 | 280005912 | 1.69 | 70 | Palliative (P) | 2017-05-04 | 2017-05-04 | Carboplatin + Etoposide IV 3 day | N | N | 280028450 | CARBOPLATIN + ETOPOSIDE |
| 280008677 | 280005914 | 1.71 | null | Neo-adjuvant (N) | 2018-02-26 | 2018-03-03 | GEMCITABINE | null | null | 280028455 | GEMCITABINE |
| 280008678 | 280010626 | 1.87 | null | null | 2017-09-10 | 2018-02-16 | Oxaliplatin + Modified de Gramont | N | N | 280028457 | OXALIPLATIN + MDG |
| 280008679 | 280005917 | 1.86 | 59.7 | Palliative (P) | 2015-08-29 | 2015-09-23 | CARBOPLATIN + ETOPOSIDE | 02 | N | 280028458 | CARBOPLATIN + ETOPOSIDE |
| 280008680 | 280005918 | 1.65 | null | null | 2015-06-15 | 2015-06-25 | Doxorubicin + Olaratumab | Y | N | 280028462 | DOXORUBICIN + OLARATUMAB |
| 280008681 | 280005918 | null | 64 | Palliative (P) | 2017-05-14 | 2017-06-05 | EW EuroEwing 99 : VActC | N | N | 280028462 | EURO-EWING |
| 280008682 | 280005919 | null | 62.2 | Palliative (P) | 2013-10-11 | 2013-11-14 | EW EuroEwing 99 : VActI | N | Y | 280028466 | EURO-EWING |
| 280008683 | 280005920 | 1.58 | 86.8 | Palliative (P) | 2014-07-05 | 2015-09-05 | CISPLATIN + FLUOROURACIL | 2 | N | 280028468 | CISPLATIN + FLUOROURACIL |
| 280008684 | 280005920 | 1.69 | 56.4 | Adjuvant (A) | 2014-08-18 | 2014-09-11 | Oxaliplatin + Modified de Gramont | null | null | 280028468 | OXALIPLATIN + MDG |
| 280008685 | 280005920 | 1.81 | 92 | Palliative (P) | 2014-12-18 | 2014-12-18 | Etoposide + Ifosfamide (5 days) | Y | N | 280028468 | ETOPOSIDE + IFOSFAMIDE |
| 280008686 | 280005921 | 1.54 | 57.4 | Palliative (P) | 2017-01-26 | 2017-02-01 | Oxaliplatin + Modified de Gramont | N | N | 280028475 | OXALIPLATIN + MDG |
| 280008687 | 280005921 | null | 0 | Palliative (P) | null | 2013-09-11 | CISPLATIN + FLUOROURACIL | 02 | N | 280028475 | CISPLATIN + FLUOROURACIL |
| 280008688 | 280005922 | 1.66 | 108 | Palliative (P) | 2016-03-08 | 2016-03-18 | Doxorubicin + Ifosfamide | 02 | N | 280028486 | DOXORUBICIN + IFOSFAMIDE |
| 280008689 | 280009101 | 1.73 | 50.3 | Curative (C) | 2016-08-21 | 2016-11-02 | Irinotecan + Modified De Gramont | 02 | N | 280028490 | IRINOTECAN + MDG |
| 280008690 | 280005923 | 1.76 | 87.3 | Palliative (P) | 2014-06-16 | 2016-01-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 280028493 | CARBOPLATIN + PACLITAXEL |
| 280008691 | 280005924 | null | 153 | Palliative (P) | 2017-01-25 | 2017-01-26 | DE-ESCALATE TRIAL | N | N | 280028496 | DE-ESCALATE TRIAL |
| 280008692 | 280005924 | 1.65 | null | Adjuvant (A) | 2016-10-15 | 2016-10-21 | Cisplatin +Fluorouracil (2 wk) | N | Y | 280028496 | CISPLATIN + FLUOROURACIL |
| 280008693 | 280011373 | 1.86 | null | Palliative (P) | 2015-07-28 | 2015-08-01 | DE-ESCALATE TRIAL | N | null | 280028501 | DE-ESCALATE TRIAL |
| 280008694 | 280011373 | 1.8 | 64.8 | Palliative (P) | 2018-08-13 | 2018-08-18 | VAI (Ifos 3g/m2) | 01 | N | 280028501 | IRINOTECAN + MDG |
| 280008696 | 280010630 | 1.39 | 72.4 | Palliative (P) | 2015-09-08 | 2015-09-08 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | 280028506 | CARBOPLATIN + PACLITAXEL |
| 280008697 | 280005928 | null | 58.7 | Adjuvant (A) | 2017-06-22 | 2017-08-07 | Etoposide + Ifosfamide (5 days) | 02 | Y | 280028510 | ETOPOSIDE + IFOSFAMIDE |
| 280008698 | 280005929 | 1.65 | null | Palliative (P) | 2018-12-25 | 2018-12-25 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280028514 | GEMCITABINE |
| 280008699 | 280009105 | null | null | Palliative (P) | 2016-04-18 | 2016-06-20 | CISPLATIN + FLUOROURACIL | N | N | 280028516 | CISPLATIN + FLUOROURACIL |
| 280008700 | 280005931 | 1.61 | 72.8 | Palliative (P) | 2015-02-21 | 2015-03-14 | DE-ESCALATE TRIAL | N | N | 280028519 | DE-ESCALATE TRIAL |
| 280008701 | 280011375 | 1.64 | null | Palliative (P) | 2017-05-13 | 2017-05-16 | Doxorubicin + Ifosfamide | null | N | 280028520 | DOXORUBICIN + IFOSFAMIDE |
| 280008702 | 280011742 | 1.74 | 83.9 | Palliative (P) | 2016-06-10 | 2016-07-01 | VAC | 2 | N | 280028522 | CAV |
| 280008703 | 280009107 | 1.7 | 59.2 | Not known (9) | 2015-12-24 | 2016-01-16 | VAI (Ifos 3g/m2) | null | null | 280028529 | VAI |
| 280008704 | 280009107 | 1.76 | 95.6 | Palliative (P) | 2016-01-04 | 2016-01-11 | Etoposide + Ifosfamide (3 days) | 2 | N | 280028529 | ETOPOSIDE + IFOSFAMIDE |
| 280008705 | 280005934 | 1.85 | 98 | Palliative (P) | 2017-05-31 | 2017-07-03 | Etoposide + Ifosfamide (3 days) | N | N | 280028533 | ETOPOSIDE + IFOSFAMIDE |
| 280008706 | 280005935 | 1.73 | 50.5 | Disease modification (D) | 2017-06-04 | 2017-07-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028550 | CISPLATIN + GEMCITABINE |